OTCMKTS:PTIX - Protagenic Therapeutics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.95 0.00 (0.00 %)
(As of 08/20/2018 06:36 AM ET)
Previous Close$1.95
Today's Range$1.95 - $1.95
52-Week Range$1.25 - $2.00
Volume1 shs
Average Volume99 shs
Market Capitalization$20.01 million
P/E RatioN/A
Dividend YieldN/A
Beta-11.98
Protagenic Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.

Receive PTIX News and Ratings via Email

Sign-up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PTIX
CUSIPN/A
Phone212-994-8200

Debt

Debt-to-Equity RatioN/A
Current Ratio2.92
Quick Ratio2.92

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.12 per share
Price / Book16.25

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-2,250,000.00
Net MarginsN/A
Return on Equity-154.13%
Return on Assets-111.60%

Miscellaneous

Employees3
Outstanding Shares10,260,000
Market Cap$20.01 million

Protagenic Therapeutics (OTCMKTS:PTIX) Frequently Asked Questions

What is Protagenic Therapeutics' stock symbol?

Protagenic Therapeutics trades on the OTCMKTS under the ticker symbol "PTIX."

How were Protagenic Therapeutics' earnings last quarter?

Protagenic Therapeutics Inc (OTCMKTS:PTIX) issued its quarterly earnings results on Tuesday, May, 15th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter. View Protagenic Therapeutics' Earnings History.

When is Protagenic Therapeutics' next earnings date?

Protagenic Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, August, 21st 2018. View Earnings Estimates for Protagenic Therapeutics.

Who are some of Protagenic Therapeutics' key competitors?

Who are Protagenic Therapeutics' key executives?

Protagenic Therapeutics' management team includes the folowing people:
  • Dr. Garo H. Armen, Co-Founder & Exec. Chairman (Age 65)
  • Dr. Alexander K. Arrow C.F.A., M.D., CFA, CFO, Compliance Officer & Sec. (Age 47)
  • Dr. Dalia Barsyte, Chief Technology Advisor
  • Dr. David A. Lovejoy, Chief Scientific Advisor
  • Ms. Christina Fam Faragalla, Director of Project Management

Has Protagenic Therapeutics been receiving favorable news coverage?

Media headlines about PTIX stock have trended somewhat positive this week, Accern reports. The research firm identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Protagenic Therapeutics earned a news impact score of 0.13 on Accern's scale. They also assigned media stories about the biotechnology company an impact score of 47.89 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for Protagenic Therapeutics.

How do I buy shares of Protagenic Therapeutics?

Shares of PTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Protagenic Therapeutics' stock price today?

One share of PTIX stock can currently be purchased for approximately $1.95.

How big of a company is Protagenic Therapeutics?

Protagenic Therapeutics has a market capitalization of $20.01 million. Protagenic Therapeutics employs 3 workers across the globe.

How can I contact Protagenic Therapeutics?

Protagenic Therapeutics' mailing address is 149 FIFTH AVENUE SUITE 500, NEW YORK NY, 10010. The biotechnology company can be reached via phone at 212-994-8200 or via email at [email protected]


MarketBeat Community Rating for Protagenic Therapeutics (OTCMKTS PTIX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  77
MarketBeat's community ratings are surveys of what our community members think about Protagenic Therapeutics and other stocks. Vote "Outperform" if you believe PTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PTIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel